Energy Efficiency, GHG Emissions, Industrial, Industrial, Sourcing Renewables  -  July 25, 2023

BD Reduces Emissions by 10%, Adds RE

BD (Becton, Dickinson and Company), a global medical technology company, lowered its Scope 1 and 2 GHG emissions by 10% in FY 2022 from a FY 2019 baseline.

The company also achieved progress toward its 2040 carbon neutral goal by increasing the number of sites using renewable electricity to 31. Of these sites, 17 are using 100% renewable electricity, five sites are using partial renewable electricity, and nine sites are utilizing onsite renewables. 

BD launched the Sustainable Medical Technology Institute and initiated partnerships with health systems, regulated waste management companies and recyclers in the U.S., Brazil, Denmark, Australia and New Zealand to explore circular economy solutions for managing BD products at end of life.

Details were issued in BD's Fiscal Year 2022 Environmental, Social and Governance (ESG) Report.

"We all have a responsibility for taking action to advance sustainability efforts and ESG issues relevant to our businesses, and at BD, we're making meaningful progress addressing our impacts on the environment and the communities where we live and work, from minimizing our environmental footprint, to empowering a diverse and inclusive workforce, and advancing health equity and access to health care in under-resourced areas of the world," said BD's chairman, CEO and president Tom Polen in a statement.